Related Experiment Video

Updated: Mar 30, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.9K

miR-195 is a key regulator of Raf1 in thyroid cancer

Fangzheng Wang1, Chuner Jiang2, Quanquan Sun1

  • 1Department of Radiation Oncology, Zhejiang Cancer Hospital, Zhejiang, Hangzhou, People's Republic of China ; Zhejiang Key Laboratory of Radiation Oncology, Zhejiang Cancer Hospital, Zhejiang, Hangzhou, People's Republic of China.

Oncotargets and Therapy
|November 4, 2015
PubMed

Insights

Proto-oncogene Raf1 is overexpressed in thyroid cancer and is targeted by miR-195. Restoring miR-195 expression inhibits Raf1, blocking cancer cell proliferation, offering a new therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Proto-oncogene Raf1 is implicated in cell signaling pathways crucial for cancer development.
  • Raf1 overexpression is observed in various cancers, but its specific role and regulation in thyroid carcinoma remain underexplored.
  • MicroRNAs (miRNAs) are emerging as key regulators in cancer, yet their interaction with Raf1 in thyroid cancer is not well understood.

Purpose of the Study:

  • To investigate the expression of Raf1 in thyroid cancer.
  • To identify specific miRNAs that directly target Raf1 in thyroid carcinoma.
  • To explore the functional impact of miRNA regulation on Raf1 and thyroid cancer cell behavior.

Main Methods:

  • Quantitative analysis of Raf1 expression in thyroid cancer tissues.
  • Dual luciferase reporter assays to confirm direct miRNA-target interactions.
  • Analysis of miRNA expression in tumor versus adjacent non-tumor thyroid tissues.
  • Cell proliferation assays following exogenous miRNA overexpression.

Main Results:

  • Raf1 is confirmed to be overexpressed in thyroid cancer.
  • Raf1 was identified as a direct target of miR-15a/b, miR-16, and miR-195.
  • miR-195 expression was significantly downregulated in thyroid tumor tissues.
  • Overexpression of miR-195 suppressed Raf1 protein levels and inhibited thyroid cancer cell proliferation.

Conclusions:

  • This study establishes Raf1 as a direct target of miR-195 in thyroid cancer.
  • Downregulation of miR-195 contributes to Raf1 overexpression in thyroid cancer.
  • miR-195-mediated regulation of Raf1 presents a potential therapeutic target for thyroid cancer treatment.
Keywords:
Raf1microRNAproliferationthyroid cancer

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.6K
Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells06:44

Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells

Published on: March 1, 2024

1.9K

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
9.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K